首页>
外国专利>
Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
展开▼
机译:新型乙酰辅酶A羧化酶(ACC)抑制剂及其在糖尿病,肥胖症和代谢综合征中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to compounds of formula (I) which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.
展开▼